Carmustine wafers (Gliadel) plus concomitant temozolomide therapy after resection of malignant astrocytoma: growing evidence for safety and efficacy.
McGirt
Matthew J
MJ
Brem
Henry
H
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001254:Astrocytoma / Q000188:drug therapy* / Q000601:surgery; D001672:Biocompatible Materials; D002330:Carmustine / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage / Q000031:analogs & derivatives; D003652:Decanoic Acids / Q000008:administration & dosage*; D004337:Drug Carriers; D006801:Humans; D011091:Polyesters / Q000008:administration & dosage*; D000077204:Temozolomide; D016896:Treatment Outcome
D001672:Biocompatible Materials; D003652:Decanoic Acids; D004337:Drug Carriers; D011091:Polyesters; D003606:Dacarbazine; C055401:decanedioic acid-4,4'-(1,3-propanediylbis(oxy))bis(benzoic acid) copolymer; D002330:Carmustine; D000077204:Temozolomide